LISBON — The diabetes and weight-loss drug semaglutide improves heart failure–related symptoms and physical limitations regardless of diuretic use in patients with obesity-related heart failure and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback